Fifth, other significant drug‐metabolizing CYPs, including CYP1A2, CYP2A6, CYP2B6, CYP2D6, CYP2E1, and CYP3A4/5, will be explored for HCC in our future studies. This evidence concerns the gene CYP2B6 and hepatocellular carcinoma.